Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 1/2016

01.01.2016 | Original Article

Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation

verfasst von: Yoshiaki Mitsutake, Takafumi Ueno, Fumiaki Ikeno, Shinji Yokoyama, Ken-ichiro Sasaki, Takaharu Nakayoshi, Naoki Itaya, Hidetoshi Chibana, Masahiro Sasaki, Yoshihiro Fukumoto

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Several studies have shown coronary endothelial dysfunction and delayed arterial healing associated with first-generation drug-eluting stents. However, it remains unclear whether those issues persist for a longer term. We thus evaluated serial changes in endothelial function and intra-stent condition after paclitaxel-eluting stents (PES) implantation. Eight patients with stable effort angina were assessed at 9 and over 24 months (1st and 2nd follow-up) after PES implantation. Endothelial function was evaluated with intracoronary infusion of acetylcholine (Ach). Vascular responses were quantitatively measured. Intra-stent condition was evaluated using angioscopy. We assessed (1) the degree of neointimal coverage over the stent (grade 0: no coverage to grade 3: full coverage); (2) presence of yellow intima inside the stent, and (3) existence of in-stent thrombus. Vasomotions proximal to the stent at 2nd follow-up significantly improved compared with 1st follow-up (p = 0.04), whereas vascular responses at the distal segment did not differ between 1st and 2nd follow-up (p = 0.19). From the angioscopic study, the average of coverage grading was comparable between the 2 points (0.9 ± 0.8 vs. 1.3 ± 1.0, p = 0.20). In addition, the incidence of yellow intima and in-stent thrombus did not differ between 1st and 2nd follow-up (yellow intima; 50 vs. 37.5 %, p = 1.0, thrombus; 75 vs. 50 %, p = 0.61). Endothelial dysfunction and delayed healing with PES could attenuate gradually, but these issues may persist over 24 months in some patients.
Literatur
1.
Zurück zum Zitat Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.PubMedCrossRef Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.PubMedCrossRef
2.
Zurück zum Zitat Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol. 2007;120:212–20.PubMedCrossRef Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol. 2007;120:212–20.PubMedCrossRef
3.
Zurück zum Zitat Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv. 2012;5:966–73.PubMedCrossRef Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv. 2012;5:966–73.PubMedCrossRef
4.
Zurück zum Zitat Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation. 2007;116:910–6.PubMedCrossRef Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation. 2007;116:910–6.PubMedCrossRef
5.
Zurück zum Zitat Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents. JACC Cardiovasc Interv. 2009;2:453–8.PubMedCrossRef Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents. JACC Cardiovasc Interv. 2009;2:453–8.PubMedCrossRef
6.
Zurück zum Zitat Yamamoto M, Takano M, Murakami D, Inami T, Kobayashi N, Inami S, et al. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy. Am Heart J. 2011;161:1200–6.PubMedCrossRef Yamamoto M, Takano M, Murakami D, Inami T, Kobayashi N, Inami S, et al. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy. Am Heart J. 2011;161:1200–6.PubMedCrossRef
7.
Zurück zum Zitat Kitahara H, Fujimoto Y, Ishikawa K, Aoki Y, Iwata Y, Kadohira T, et al. Recovery of endothelial function after sirolimus-eluting stent implantation: a pilot study. Angiology. 2013;64:211–5.PubMedCrossRef Kitahara H, Fujimoto Y, Ishikawa K, Aoki Y, Iwata Y, Kadohira T, et al. Recovery of endothelial function after sirolimus-eluting stent implantation: a pilot study. Angiology. 2013;64:211–5.PubMedCrossRef
8.
Zurück zum Zitat Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.PubMedCrossRef Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.PubMedCrossRef
9.
Zurück zum Zitat Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.PubMedCrossRef Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.PubMedCrossRef
10.
Zurück zum Zitat Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906.PubMedCrossRef Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–906.PubMedCrossRef
11.
Zurück zum Zitat Sakai S, Mizuno K, Yokoyama S, Tanabe J, Shinada T, Seimiya K, et al. Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study. J Am Coll Cardiol. 2003;42:1558–65.PubMedCrossRef Sakai S, Mizuno K, Yokoyama S, Tanabe J, Shinada T, Seimiya K, et al. Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study. J Am Coll Cardiol. 2003;42:1558–65.PubMedCrossRef
12.
Zurück zum Zitat Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999;34:631–8.PubMedCrossRef Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999;34:631–8.PubMedCrossRef
13.
Zurück zum Zitat Sahler LG, Davis D, Saad WE, Patel NC, Lee DE, Waldman DL. Comparison of vasa vasorum after intravascular stent placement with sirolimus drug-eluting and bare metal stents. J Med Imaging Radiat Oncol. 2008;52:570–5.PubMedCrossRef Sahler LG, Davis D, Saad WE, Patel NC, Lee DE, Waldman DL. Comparison of vasa vasorum after intravascular stent placement with sirolimus drug-eluting and bare metal stents. J Med Imaging Radiat Oncol. 2008;52:570–5.PubMedCrossRef
14.
Zurück zum Zitat Pendyala LK, Li J, Shinke T, Geva S, Yin X, Chen JP, et al. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc Interv. 2009;2:253–62.PubMedCrossRef Pendyala LK, Li J, Shinke T, Geva S, Yin X, Chen JP, et al. Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc Interv. 2009;2:253–62.PubMedCrossRef
15.
Zurück zum Zitat Ikeda H, Koga Y, Oda T, Kuwano K, Nakayama H, Ueno T, et al. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J Am Coll Cardiol. 1994;24:1749–56.PubMedCrossRef Ikeda H, Koga Y, Oda T, Kuwano K, Nakayama H, Ueno T, et al. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J Am Coll Cardiol. 1994;24:1749–56.PubMedCrossRef
16.
Zurück zum Zitat Eguchi H, Ikeda H, Murohara T, Yasukawa H, Haramaki N, Sakisaka S, et al. Endothelial injured of coronary arteries distal to thrombotic sites: role of adhesive interaction between endothelial P-selectin and leukocyte sialyl lewis X. Circ Res. 1999;84:525–35.PubMedCrossRef Eguchi H, Ikeda H, Murohara T, Yasukawa H, Haramaki N, Sakisaka S, et al. Endothelial injured of coronary arteries distal to thrombotic sites: role of adhesive interaction between endothelial P-selectin and leukocyte sialyl lewis X. Circ Res. 1999;84:525–35.PubMedCrossRef
17.
Zurück zum Zitat Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J. 2004;148:333–5.PubMedCrossRef Ueda Y, Ohtani T, Shimizu M, Hirayama A, Kodama K. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J. 2004;148:333–5.PubMedCrossRef
18.
Zurück zum Zitat Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation. JACC Cardiovasc Interv. 2008;1:74–80.PubMedCrossRef Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation. JACC Cardiovasc Interv. 2008;1:74–80.PubMedCrossRef
19.
Zurück zum Zitat Ikenaga H, Ishihara M, Dai K, Nakama Y, Ohtani T. Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography. JACC Cardiovasc Imaging. 2011;4:1217–9.PubMedCrossRef Ikenaga H, Ishihara M, Dai K, Nakama Y, Ohtani T. Mechanisms of very late stent thrombosis after drug-eluting stent implantation: findings from coronary angioscopy and optical coherence tomography. JACC Cardiovasc Imaging. 2011;4:1217–9.PubMedCrossRef
20.
Zurück zum Zitat Bauters C, Lablanche JM, Renaud N, McFadden EP, Hamon M, Bertrand ME. Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J. 1996;17:1554–9.PubMedCrossRef Bauters C, Lablanche JM, Renaud N, McFadden EP, Hamon M, Bertrand ME. Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J. 1996;17:1554–9.PubMedCrossRef
Metadaten
Titel
Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation
verfasst von
Yoshiaki Mitsutake
Takafumi Ueno
Fumiaki Ikeno
Shinji Yokoyama
Ken-ichiro Sasaki
Takaharu Nakayoshi
Naoki Itaya
Hidetoshi Chibana
Masahiro Sasaki
Yoshihiro Fukumoto
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 1/2016
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-015-0341-5

Weitere Artikel der Ausgabe 1/2016

Cardiovascular Intervention and Therapeutics 1/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.